DAFTAR PUSTAKA
Ahuja, J., Basu, A. 2012. Study of C-Reactive Protein Level in Patients of Acute Ishemic Stroke and Its Correlation With Serum Lipid Profile. Intenational Journal of Health Sciences and Research; 2(3):40-48. American Joint Committee on Cancer. 2003. Comparison Guide: Fifth Versus Sixth Edition. Available at : http://www.cancerstaging.org/products/ajccguide.pdf Arenillas, J.F., Sabin, J.A., Molina, C.A., Chacon, P., Montaner, J., Rovira, A., et al. 2003. C- Reactive Protein Predicts Further Ischemic Events in First Ever Transient Ischemic Attack or Stroke Patients with Intracranial Large Artery Occlusive Disease.Stroke. 34:24632470. Attyẻ, A., Boncoeur-Martel, M.P., Maubon, A., Mounayer, C., Couratier, P., Labrunie, A., Le Bas, J.F. 2012. Diffusion-Weighted Imaging infarct volume and neurologic outcomes after ischemic stroke. J Neuroradiol. May;39(2):97-103 Barrett, K.M., Ding, Y.H., Wagner, D.P., Kallmes, D.F., Johnston, K.C. 2009. Change in Diffusion-Weighted Imaging Infarct Volume Predicts Neurologic Outcome at 90 Days Results of the Acute Stroke Accurate Prediction (ASAP) Trial Serial Imaging Substudy. Stroke. 40:2422-2427. Black, S., Kusher, I., Samols, D. 2004. Minireview : C-reactive protein. J. Biol. Chem; 279:48487-48490. Braunwald, E. Congestive Heart Failure and Cor Pulmonale. In: Kasper, D.L., Braunwald, E., Fauci, A.S., Hauser, S.L., Longo, D.L., Jameson, J.L., editors. Harrison’s Manual of Medicine 16th edition. New York. McGraw-Hill; 2005. p648-652 Canova, C.R., Courtin, C., Reinhart, W.H. C-reactive protein (CRP) in cerebro-vsculsr events. Atherosclerosis. 1999 Nov 1;147(1):49-53 Caplan, L.R. 2009. Caplan’s Stroke: A Clinical Approach. 4th ed. Saunders. Elsevier Philadelphia.p 89-92 CDC/NHSN Protocol Clarifications. 2013. CDC/NHSN Surveillance Definitions for spesific Types of Infections. 17-1 – 60.
63
Ćorić, J., Pašić, A., Panjeta, M., Mujić, J. 2012.Evaluation of high sensitivity C – reactive protein assay in cerebrospinal fluid on the Dimension RxL analyzer. Journal of Health Sciences; 2(1):13-6 Dar, M.S., Pandith, A.A., Samee, A.S., Sultan, M., Yousuf, A., Mudassar, S. Hs-CRP : A potential Marker for Hypertension in Khasmiri Population. Indian Journal of Clinical Biochemistry, 2010 / 25 (2) 208-212 Dewan, K.R., Rana, P.V.S. 2011. C-Reactive Protein and Early Mortality in Acute Ischemic Stroke. Kathmandu Univ Med J; 36(4):252-5. Di Napoli, M., Elkind, M. S., Godoy, D.A., Singh, P.,Papa, F., PopaWagner, A. 2011. Role of C-Reactive Protein in Cerebrovascular Disease. Expert Rev Cardiovasc Ther. 9(12):1565-1584. Di Napoli, M., Papa, F., Bocola, V. 2001. Prognostic Influence of Increase C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke. Stroke.32:133-138. Di Napoli, M., Papa, F., Bocola V. 2001. C-Reactive Protein in Ischemic Stroke : An Independent Prognostic Factor. Stroke. 32: 917-92 Di Napoli, M., Schwaninger, M., Cappelli, R., Ceccarelli, E., Gianfilipo, G., Donati, C., et al. 2005. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosisin Ischemic Stroke : a Statement for Health Care Proffesionals From the CRP Pooling Project Members. Stroke. 36: 1316-1329. Elkind, M.S.V. 2010. Inflammatory Mechanism of Stroke. Stroke.41: S3S8. Farhoudi, M., Najafi-Nesheli, M., Hashemilar, M., Mahmoodpoor, A.,Ehsan Sharifipour, E., Baradaran, B., et al. 2013. Effect of IMOD™ on the inflammatory process after acute ischemic stroke: a randomized clinical trial. Daru; 21(1): 26. Furlan, A.J. 2001. Perfusion –Weighted CT in Acute MCA Stroke : Teaching Old Dogs New Tricks. Stroke. 32 : 2027-28. Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., et al. 2006. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. European Heart Journal. 27: 1979-2030
Ghabaee, M., Zandieh, A., Mohebbi, S., Fakhri, M., Sadeghian, H., Divani, F., et al. 2013. Predictive Ability of C-Reactive Protein for Early mortality after ischemic stroke; Comparison with NIHSS Score. Acta Neurologica Belgica. Gofir, A. 2009. Manajemen Stroke. Evidence Based Medicine. Pustaka Cendekia Press. Yogyakarta. Hamidon, B B., Sapiah, S., Nawawi, H., Raymond, A A. 2004. The Prognostic Value of C-Reactive Protein (CRP) Levels in Patients with Acute Ischaemic Stroke. Med J Malaysia; Vol 59 (5): 631-7. Harukuni, I., Bhardwaj, A. 2006. Mechanisms of Brain Injury after Global Cerebral Ischemia. Neurol Clin 24: 1–21 Hertog, H.M., Rossum, J.A., Van der Worp,H.B., Van Gemert, H.M.A., de Jonge,R., Koudstall,P.J., Dippel,D.W. 2009. C-Reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol.259:2003-2008. Hirschfield, G.M., Pepys, M,B. 2003. C-Reactive Protein and Cardiovascular disease: New Insight from an Old Molecule. QJ Med; 96:793-807. Husain, T.M., Kim, D.H. 2002. C-Reactive Protein and Erythrocyte Sedimentation Ratein Orthopaedics. The University of Pennsylvania Orthopaedic Journal15: 13–16 Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. 2009. Admission C - reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The `Bergen stroke study. BMC Neurology 9:18. Jialal, I., Devaraj, S. 2001. Inflammation and AtherosclerosisThe Value of the High-Sensitivity C-Reactive Protein Assay as a Risk Marker Am J ClinPathol;116 (Suppl 1):S108-S115 Johnson, K. 2012. Liver Failure. Digestive Disorders Health Center. Available at: http://www.webmd.com/digestive-disorders/digestivediseases-liver-failure Kara, H., Akinci, M., Degirmenci, S.,Bayir, A., Ak, A., Nayman A., et al. High-sensitivity C-reactive protein, lipoprotein-related phospholipase A, and acute ischemic stroke. Neuropsychiatric Disease and Treatment 2014:10 1451–1457
KDIGO Clinical Practice Guideline for Acute Kidney Injury. 2012. Kidney International Supplements. 2:19–36 Lakhan, E.S., Kirchgessner, A., Hofer, M. 2009. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. Journal of Translational Medicine 7:97. Lambert, M. 2011. AHA/ASA Guidelines on Prevention of Recurrent Stroke. Am Fam Physician. Apr 15;83(8):993-100 Madiyono, B., Moeslichan, M., Budiman, I., Purwanto, S.H. 2008. Perkiraan Besar Sampel. Dalam : Sastroasmoro S, Ismael S, editor. Dasar-dasar Metodologi Penelitian Klinis. Jakarta : Sagung Seto; hal 302-331 Marquardt, L., Ruf, A., Mansmann, U., Winter, R., Buggle, F., Kallenberg, K., Grau, A. J. 2005. Inflammatory response after acute ischemic stroke. J Neurol Sci. 236(1-2):65-71. Masotti, L., Ceccarelli, E., Forconi, S., Cappelli, R. 2005. Prognostic role of C-Reactive Protein in very old patients with acute ischemic stroke. Misbach, J., Lamsudin, R., Aliah, A., Basyiruddin, Suroto, Nurimaba, N., et al. Kelompok Studi Stroke Perhimpunan Dokter Spesialis Saraf Indonesia. 2011. Guideline Stroke. Perdossi. Jakarta. Misbach, J. 2011. Stroke : Aspek diagnostik, patofisiologi, manajemen. Badan Penerbit FKUI. Muir, K.W., Weir, J.C., Alwan, W., Squire, B.I., Lees, K.R. 1999. CReactive Protein and Outcome After Ischemic Stroke. Stroke 30:981-985. Nighoghossian, N., Wiart, M., Cakmak, S., Berthezene, Y., Derex, L., Cho, T.H., et al. 2007. Inflamatory response after Ishemic Stroke: A USPIO-Enhanced MRI study in Patients. Stroke.38:303-307. Ormstad, H.,Aass, H.C.,Lund-Sorensen, N., Amthor, K.F., Sandvik, L. 2011. Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. . J Neurol.258(4):677-685 Osmani A., Durrani R., Ara J. 2010. Comparison of Outcome in Different Types of Stroke Due to Cerebral Ischemia. Journal of the College of Physicians and Surgeons Pakistan.20(1):42-46
Pantano, P., Caramia, F., Bozzao, L., Dieler C., and von Kummer, R. 1999. Delayed Increase in Infarct Volume After Cerebral Ischemia : Correlations with Thrombolytic Treatment and Clinical Outcome. Stroke. 30:502-507 Pepys, M.B. The acute phase response and C-Reactive Protein. Oxford Textbook of Medicine. 2nd ed. Oxford, UK: Oxford University Press; 1995:1527-1533. Rahman, M.M., Rabim, M.A., Nath, R.K., Al-Mahmood, A.K., Mollah, F.H. 2011. Prognostic role of C-reactive protein in acute stroke. Bangladesh Journal of Medical Science; 10(1): 29-33. Rajeshwar K, Kaul S, Al-Hazzani,A., Babu MS, Balakrishna N, Sharma V, Jyothy A, Munshi A. 2012. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome. Inflammation; 35(3):978-84 Roger, L.V., Go, S.A., Lloyd-Jones, D.M., Adams, J.R., Berry,J.D., Brown, T.D., et al. 2011. Heart Disease and Stroke Statistics—2011 Update A Report From the American Heart Association. Circulation;123:e18-e209. Roudbary, S.A., Saadat, F., Forganpharast, K., Sohrabnejad,R. 2011. Serum C- Reactive Protein Level as a Biomarker for differentiation of Ischemic Stroke from hemorrhagic Stroke. Acta Medica Iranica; 49(3):149-152. Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R.,Culebras, A., Elkind, M.S.V.,et al. 2013. An Update Defenition of Stroke for the 21st Century: a Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke; 44:2064-2089. Saver, J.L., Johnston, K.C., Homer, D., Wityk, R., Koroshetz, W., Truskowski, L.L., Haley, E.C. 1999. Infarct Volume as a Surrogate or Auxiliary Outcome Measure in Ischemic Stroke Clinical Trials. Semple, S.j. 2006. C-reactive Protein –Biological function, cardiovascular disease and physical exercise. SAJSM; 18(1):24-28. Shaikh, M.K., Makhija, P., Baloch, Z.A.Q., Mughal, M.F., Devrajani, B.R., Shaikh, S., Das, T. 2011. C-Reactive Protein in Patients with Ischemic Stroke. World Applied Sciences Journal 15(9): 1220-1224.
Sims, J.R., Gharai, L.R., Schaefer, P.W., Vangel, M., Rosenthal, E.S., Lev, M.H., and Schwamm, L.H. 2009. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology June 16. Vol.72 no.24 2104-2110 Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung Medan. Smith, C.J., Emsley, H.C.A., Gavin, C.M., Georgiou, R.F., Vail, A., Barberan, E.M., et al. 2001. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and longterm outcome. BMC Neurology.4:2. Taheraghdam , A., Aminnejad, S., Pashapour, A., Rikhtegar, R., Ghabil, K. 2013. Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke? Pak J Med Sci. 29(1):166169. Truelsen, T., Piechonski-Jozwiak, B., Bonita, R., et al. 2006. Stroke Incidence and Prevalence in Europe: a review of available data. European Journal of Neurology. 13(6):581-589. US Food and Drug Administration. Review criteria for assessmentof Creactive protein (CRP), high sensitivity C-reactive protein, and cardiac C-reactive protein (cCRP) assays. 2005. http://www.fda.gov/cdrh/oivd/guidance/1246.pdf Weimar, C., Kurth, T., Kraywinkel, K., Wagner, M., Busse, O., Haberl, R. L., Diener, H. S. 2002. Assessment of Functioning and Disability After Ischemic Stroke. Stroke. 33:2053-2059. Winbeck, K., Poppert, H., Etgen, T., Conrad, B., Sander, D. 2002. Prognostic Relevance of Early C-Reactive protein Measurement After Ischemic stroke. Stroke; 33: 2459-2464. Youn, C.S., Choi,S.P., Kim,H.S., Oh, S.H., Jeong, W.J., Kim,J.H., Park, K.N. 2012. Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. Am J Emerg Med 30(1):124-8
